Status | Study |
Not yet recruiting |
Study Name: Cyclophosphamide vs. Infliximab for Refractory Idiopathic Scleritis (CIRIS) Condition: Idiopathic Refractory Scleritis Date: 2017-03-17 Interventions: Drug: Infliximab Patients will |
Completed |
Study Name: Perichondrium Autograft in Refractory Necrotizing Scleritis Condition: Necrotizing Scleritis Date: 2016-07-21 Interventions: Procedure: Perichondrium Autografts Perichondrium tissue was harvested from the patient's ear cartilage |
Completed |
Study Name: Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients Condition: Uveitis Anterior Uveitis Intermediate Uveitis Date: 2016-04-25 Interventions: Drug: H.P. ACTHAR SUBCUTANEOUS GEL INJECTION Subcutaneous injection twice weekly |
Completed |
Study Name: Optical Coherence Tomography in the Diagnosis of Scleritis and Episcleritis Condition: Scleritis and Episcleritis Date: 2013-10-07 Interventions: Other: Optical Coherence Tomography |
Completed |
Study Name: Gevokizumab for Active Scleritis Condition: Scleritis Date: 2013-04-16 Interventions: Device: Gevokizumab Subcutaneous injection of 60 mg gevokizumab |
Completed |
Study Name: Causes of Visual Loss in Retinal Disease Condition: Uveitis Scleritis Date: 2012-05-29 Interventions: Drug: Immunosuppressive Agents Treatment with systemic corticosteroids and/or immunosuppressive agents T |
Completed |
Study Name: Sirolimus Injections for Autoimmune Scleritis Condition: Scleritis Date: 2012-01-24 Interventions: Drug: Sirolimus Subconjunctival injection Other Name |
Completed |
Study Name: Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study Condition: Non-infectious, Non-necrotizing Anterior Scleritis Date: 2010-01-28 Interventions: Drug: Dexamethasone Phosphate Ophthalmic Solution (EGP-437) |
Completed |
Study Name: Human Samples and Data Repository Condition: Uveitis Scleritis Date: 2007-10-03 |
Completed |
Study Name: Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation Condition: Scleritis Orbital Disease Date: 2006-12-21 Interventions: Drug: Rituximab Two 500 or 1000mg infusions over 2 weeks with the option of retreating after 6 months if |